CONFLICTS OF INTEREST:No potential conflict of interest relevant to this article was re- ported.
No potential conflict of interest relevant to this article was re- ported.
ACKNOWLEDGMENTS
This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Re- public of Korea (No. HI14C2476). H.B. was partly supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant UL1 TR 000002. D.K. was partly supported by a grant of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Re- public of Korea (HI13C0715).
ORCID
Yong-ho Lee http://orcid.org/0000-0002-6219-4942
Dae Jung Kim http://orcid.org/0000-0003-1025-2044
REFERENCES
1. Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what, why, and how? BMJ 2009;338:b375.
2. Hemingway H, Croft P, Perel P, Hayden JA, Abrams K, Timmis A, et al. Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ 2013;346:e5595.
3. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Rich- ardson WS. Evidence based medicine: what it is and what it isn’t. BMJ 1996;312:71-2.
4. Greenland S. The need for reorientation toward cost-effective prediction: comments on ‘Evaluating the added predictive ability of a new marker. From area under the ROC curve to re- classification and beyond’ by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929). Stat Med 2008;27:199- 206.
5. Lim NK, Park SH, Choi SJ, Lee KS, Park HY. A risk score for predicting the incidence of type 2 diabetes in a middle- aged Korean cohort: the Korean genome and epidemiology study. Circ J 2012;76:1904-10.
6. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type 2 diabe- tes in general practice. Diabetes Metab Res Rev 2000;16:164- 71.
7. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Associa- tion Task Force on Practice Guidelines. Circulation 2014;129 (25 Suppl 2):S49-73.
8. Steyerberg EW, Vergouwe Y. Towards better clinical pre- diction models: seven steps for development and an ABCD for validation. Eur Heart J 2014;35:1925-31.
9. Royston P, Moons KG, Altman DG, Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ 2009;338:b604.
10. Altman DG, Vergouwe Y, Royston P, Moons KG. Progno- sis and prognostic research: validating a prognostic model. BMJ 2009;338:b605.
11. Moons KG, Altman DG, Vergouwe Y, Royston P. Prognosis and prognostic research: application and impact of prog- nostic models in clinical practice. BMJ 2009;338:b606.
Lee YH, et al.
44 www.e-enm.org Copyright © 2016 Korean Endocrine Society
12. Laupacis A, Sekar N, Stiell IG. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA 1997;277:488-94.
13. Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med 2000;19:453-73.
14. Steyerberg EW. Clinical prediction models: a practical ap- proach to development, validation, and updating. New York: Springer; 2009.
15. Steyerberg EW, Moons KG, van der Windt DA, Hayden JA, Perel P, Schroter S, et al. Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med 2013;10:e1001381.
16. Collins GS, Reitsma JB, Altman DG, Moons KG. Transpar- ent Reporting of a multivariable prediction model for Indi- vidual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med 2015;162:55-63.
17. Liu J, Hong Y, D’Agostino RB Sr, Wu Z, Wang W, Sun J, et al. Predictive value for the Chinese population of the Fram- ingham CHD risk assessment tool compared with the Chi- nese Multi-Provincial Cohort Study. JAMA 2004;291:2591- 9.
18. Jee SH, Jang Y, Oh DJ, Oh BH, Lee SH, Park SW, et al. A coronary heart disease prediction model: the Korean Heart Study. BMJ Open 2014;4:e005025.
19. Lee YH, Bang H, Park YM, Bae JC, Lee BW, Kang ES, et al. Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores. PLoS One 2014;9:e107584.
20. Bang H, Edwards AM, Bomback AS, Ballantyne CM, Bril- lon D, Callahan MA, et al. Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med 2009;151:775-83.
21. Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, Johansson LM, et al. Prediction of non-alco- holic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 2009;137:865-72.
22. Harrell FE Jr. Regression modeling strategies: with applica- tions to linear models, logistic regression, and survival analysis. New York: Springer; 2001.
23. Sun GW, Shook TL, Kay GL. Inappropriate use of bivari-
able analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol 1996;49:907-16.
24. Royston P, Altman DG, Sauerbrei W. Dichotomizing con- tinuous predictors in multiple regression: a bad idea. Stat Med 2006;25:127-41.
25. Boersma E, Poldermans D, Bax JJ, Steyerberg EW, Thom- son IR, Banga JD, et al. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobu- tamine echocardiography, and beta-blocker therapy. JAMA 2001;285:1865-73.
26. Sauerbrei W. The use of resampling methods to simplify re- gression models in medical statistics. J R Stat Soc Ser C Appl Stat 1999;48:313-29.
27. Shmueli G. To explain or to predict? Stat Sci 2010:289-310. 28. Heikes KE, Eddy DM, Arondekar B, Schlessinger L. Diabe-
tes risk calculator: a simple tool for detecting undiagnosed diabetes and pre-diabetes. Diabetes Care 2008;31:1040-5.
29. Breiman L, Friedman J, Stone CJ, Olshen RA. Classifica- tion and regression trees. Belmont: Wadsworth Internation- al Group; 1984.
30. Breiman L. Statistical modeling: the two cultures (with com- ments and a rejoinder by the author). Statist Sci 2001;16:199- 231.
31. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of predic- tion models: a framework for traditional and novel mea- sures. Epidemiology 2010;21:128-38.
32. Meffert PJ, Baumeister SE, Lerch MM, Mayerle J, Kratzer W, Volzke H. Development, external validation, and com- parative assessment of a new diagnostic score for hepatic steatosis. Am J Gastroenterol 2014;109:1404-14.
33. Hilden J. Commentary: on NRI, IDI, and “good-looking” sta- tistics with nothing underneath. Epidemiology 2014;25:265- 7.
34. Lee YH, Bang H, Kim HC, Kim HM, Park SW, Kim DJ. A simple screening score for diabetes for the Korean popula- tion: development, validation, and comparison with other scores. Diabetes Care 2012;35:1723-30.
35. Wyatt JC, Altman DG. Commentary: Prognostic models: clinically useful or quickly forgotten? BMJ 1995;311:1539.